|
WO9827984A1
|
|
METHOD OF PRODUCING ANALGESIA BY ADMINISTRATION OF 1,2,3,4-TETRAHYDROBENZO-[b]THIENO[2,3-c]PYRIDINE AND DERIVATIVES
|
|
US5824645A
|
|
Method of treating inflammation
|
|
CA2224795A1
|
|
Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders
|
|
US5770690A
|
|
Bax omega protein and methods
|
|
US5795864A
|
|
Stable omega conopetide formulations
|
|
WO9504144A1
|
|
Dna encoding a human calcium channel alpha-1e subunit
|
|
CA2151741A1
|
|
Methods of producing analgesia and enhancing opiate analgesia
|
|
WO9310145A1
|
|
Compositions for delayed treatment of ischemia-related neuronal damage
|
|
US5264371A
|
|
Screening method for neuroprotective compounds
|
|
US5559095A
|
|
Delayed treatment method of reducing ischemia-related neuronal damage
|
|
AU8499691A
|
|
Method and composition for detecting bioactive peptides
|
|
US5169852A
|
|
Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives
|
|
US5189020A
|
|
Method of reducing neuronal damage using omega conotoxin peptides
|
|
US5051403A
|
|
Method of treating ischemia-related neuronal damage
|
|
AU4079389A
|
|
Method for modifying feeding behavior
|
|
US4978669A
|
|
Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives
|
|
US4971974A
|
|
Benzothiophenes as appetite suppressants
|
|
US4771001A
|
|
Production of lactic acid by continuous fermentation using an inexpensive raw material and a simplified method of lactic acid purification
|
